Ozempic Policy Debate Heats Up in Minnesota as Celebrity Health Rumors Swirl Around Weight Loss Drugs

About this episode

The episode discusses the heated policy debate in Minnesota regarding Ozempic and weight loss drugs amidst celebrity health rumors, particularly focusing on Oprah Winfrey.

In the past week, discussions around Ozempic and weight loss drugs have intensified, blending policy debates with celebrity health rumors. Minnesota lawmakers grappled with costs in the House Health Finance and Policy Committee, where a bill, HF4142, sponsored by Representative something, aimed to prohibit Medical Assistance coverage for prescription drugs used solely for weight loss like Ozempic. The measure was laid over, sparking questions on whether funding these medications saves money long-term by preventing obesity-related illnesses. According to the Minnesota House Session Daily report from late March 2026, supporters argued that covering such drugs now could reduce future expenses for comorbidities stemming from obesity. Oprah Winfrey remains at the center of Ozempic-related chatter, with fresh rumors about so-called Ozempic feet resurfacing after her appearances at Paris Fashion Week earlier this month. Nicki Swift reports that videos from the event showed Winfrey walking with slow, short steps, prompting online speculation that the GLP-1 drug, which she has used for weight management, weakened her muscles and caused sagging, veiny skin on her feet. Observers on X noted…

Topics covered

• Ozempic
• weight loss drugs
• health policy
• celebrity health rumors
• obesity-related illnesses

Keywords

• Ozempic
• weight loss
• health policy
• Oprah Winfrey
• GLP-1 medications
• obesity
• Minnesota

Mentioned in this episode

Organizations: Minnesota House Health Finance and Policy Committee

Products: Ozempic, GLP-1 medications

Places: Minnesota

More episodes of Oprah's Weight Loss Dilemma: The Ozempic

• Unable to Generate Ozempic Headline Without Relevant Search Results Data · May 2, 2026 · 1 min
• ChatGPT Under Investigation for Florida State University Shooting Investigation Reveals AI Safety Concerns · April 25, 2026 · 3 min
• AI Bias Tools and Security Risks Emerge as Developers Face New Challenges in Text to Image and Coding Systems · April 22, 2026 · 2 min
• Ozempic Weight Loss Updates April 2026: Doctors Emphasize Lifestyle Changes Alongside Medication · April 18, 2026 · 2 min
• Ozempic Shortage Crisis 2026 Demand Surges as Novo Nordisk Struggles with Supply Chain Delays · April 11, 2026 · 3 min
• Florida Law Enforcement Warns Against AI Deepfake Crime Videos as Pranks Waste Critical Resources · April 8, 2026 · 3 min